Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryan, G. R.
Right arrow Articles by Stanley, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryan, G. R.
Right arrow Articles by Stanley, E. R.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Gene Expression
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1 July 2001, Vol. 98, No. 1, pp. 74-84

HEMATOPOIESIS

Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1op/Csf1op) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis

Gregory R. Ryan, Xu-Ming Dai, Melissa G. Dominguez, Wei Tong, Fenchi Chuan, Orin Chisholm, Robert G. Russell, Jeffrey W. Pollard, and E. Richard Stanley

From the Departments of Developmental and Molecular Biology, Pathology, and Obstetrics and Gynecology, Albert Einstein College of Medicine, Bronx, New York.

Colony-stimulating factor 1 (CSF-1) regulates the survival, proliferation, and differentiation of mononuclear phagocytes. It is expressed as a secreted glycoprotein or proteoglycan found in the circulation or as a biologically active cell-surface glycoprotein. To investigate tissue CSF-1 regulation, CSF-1-null Csf1op/Csf1op mice expressing transgenes encoding the full-length membrane-spanning CSF-1 precursor driven by 3.13 kilobases of the mouse CSF-1 promoter and first intron were characterized. Transgene expression corrected the gross osteopetrotic, neurologic, weight, tooth, and reproductive defects of Csf1op/Csf1op mice. Detailed analysis of one transgenic line revealed that circulating CSF-1, tissue macrophage numbers, hematopoietic tissue cellularity, and hematopoietic parameters were normalized. Tissue CSF-1 levels were normal except for elevations in 4 secretory tissues. Skin fibroblasts from the transgenic mice secreted normal amounts of CSF-1 but also expressed some cell-surface CSF-1. Also, lacZ driven by the same promoter/first intron revealed beta -galactosidase expression in hematopoietic, reproductive, and other tissue locations proximal to CSF-1 cellular targets, consistent with local regulation by CSF-1 at these sites. These studies indicate that the 3.13-kilobase promoter/first intron confers essentially normal CSF-1 expression. They also pinpoint new cellular sites of CSF-1 expression, including ovarian granulosa cells, mammary ductal epithelium, testicular Leydig cells, serous acinar cells of salivary gland, Paneth cells of the small intestine, as well as local sites in several other tissues.

© 2001 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
R. M. Tamimi, J. S. Brugge, M. L. Freedman, A. Miron, J. D. Iglehart, G. A. Colditz, and S. E. Hankinson
Circulating Colony Stimulating Factor-1 and Breast Cancer Risk
Cancer Res., January 1, 2008; 68(1): 18 - 21.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Horiuchi, T. Miyamoto, H. Takaishi, A. Hakozaki, N. Kosaki, Y. Miyauchi, M. Furukawa, J. Takito, H. Kaneko, K. Matsuzaki, et al.
Cell Surface Colony-Stimulating Factor 1 Can Be Cleaved by TNF-{alpha} Converting Enzyme or Endocytosed in a Clathrin-Dependent Manner
J. Immunol., November 15, 2007; 179(10): 6715 - 6724.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Wei, X.-M. Dai, and E. R. Stanley
Transgenic expression of CSF-1 in CSF-1 receptor-expressing cells leads to macrophage activation, osteoporosis, and early death
J. Leukoc. Biol., December 1, 2006; 80(6): 1445 - 1453.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-H. Jang, D. M. Herber, X. Jiang, S. Nandi, X.-M. Dai, G. Zeller, E. R. Stanley, and V. R. Kelley
Distinct In Vivo Roles of Colony-Stimulating Factor-1 Isoforms in Renal Inflammation
J. Immunol., September 15, 2006; 177(6): 4055 - 4063.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Paulus, E. R. Stanley, R. Schafer, D. Abraham, and S. Aharinejad
Colony-stimulating factor-1 antibody reverses chemoresistance in human mcf-7 breast cancer xenografts.
Cancer Res., April 15, 2006; 66(8): 4349 - 4356.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Ovadia, K. Insogna, and G.-Q. Yao
The Cell-Surface Isoform of Colony Stimulating Factor 1 (CSF1) Restores but Does Not Completely Normalize Fecundity in CSF1-Deficient Mice
Biol Reprod, February 1, 2006; 74(2): 331 - 336.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Nandi, M. P. Akhter, M. F. Seifert, X.-M. Dai, and E. R. Stanley
Developmental and functional significance of the CSF-1 proteoglycan chondroitin sulfate chain
Blood, January 15, 2006; 107(2): 786 - 795.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Lenda, E. R. Stanley, and V. R. Kelley
Negative Role of Colony-Stimulating Factor-1 in Macrophage, T Cell, and B Cell Mediated Autoimmune Disease in MRL-Faslpr Mice
J. Immunol., October 1, 2004; 173(7): 4744 - 4754.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth
Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification
Endocr. Rev., August 1, 2004; 25(4): 629 - 672.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Aharinejad, P. Paulus, M. Sioud, M. Hofmann, K. Zins, R. Schafer, E. R. Stanley, and D. Abraham
Colony-Stimulating Factor-1 Blockade by Antisense Oligonucleotides and Small Interfering RNAs Suppresses Growth of Human Mammary Tumor Xenografts in Mice
Cancer Res., August 1, 2004; 64(15): 5378 - 5384.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X.-M. Dai, X.-H. Zong, V. Sylvestre, and E. R. Stanley
Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1
Blood, February 1, 2004; 103(3): 1114 - 1123.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
E. Sapi
The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update
Experimental Biology and Medicine, January 1, 2004; 229(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G.-Q. Yao, J.-J. Wu, B.-H. Sun, N. Troiano, M. A. Mitnick, and K. Insogna
The Cell Surface Form of Colony-Stimulating Factor-1 Is Biologically Active in Bone in Vivo
Endocrinology, August 1, 2003; 144(8): 3677 - 3682.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
S. L. Abboud, M. Bunegin, N. Ghosh-Choudhury, and K. Woodruff
Analysis of the Mouse CSF-1 Gene Promoter in a Transgenic Mouse Model
J. Histochem. Cytochem., July 1, 2003; 51(7): 941 - 949.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Ide, D. B. Seligson, S. Memarzadeh, L. Xin, S. Horvath, P. Dubey, M. B. Flick, B. M. Kacinski, A. Palotie, and O. N. Witte
Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression
PNAS, October 29, 2002; 99(22): 14404 - 14409.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. A. Hume, I. L. Ross, S. R. Himes, R. T. Sasmono, C. A. Wells, and T. Ravasi
The mononuclear phagocyte system revisited
J. Leukoc. Biol., October 1, 2002; 72(4): 621 - 627.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Aharinejad, D. Abraham, P. Paulus, H. Abri, M. Hofmann, K. Grossschmidt, R. Schafer, E. R. Stanley, and R. Hofbauer
Colony-stimulating Factor-1 Antisense Treatment Suppresses Growth of Human Tumor Xenografts in Mice
Cancer Res., September 15, 2002; 62(18): 5317 - 5324.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. E. Cohen, L. Zhu, K. Nishimura, and J. W. Pollard
Colony-Stimulating Factor 1 Regulation of Neuroendocrine Pathways that Control Gonadal Function in Mice
Endocrinology, April 1, 2002; 143(4): 1413 - 1422.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020